PLIVA Kraków Pharmaceutical Plants S.A. Teva Operations Polska Sp. z o.o.

The medicinal product is used in the treatment of chronic myeloproliferative disorders (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, and myelofibrosis) and in sickle cell anemia, to prevent the recurrence of painful crises.

Dosage form: capsules

ATC: L01XX05